Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: Improved follow-up results

American Journal of Neuroradiology

Volumn 30, Issue 9, 2009, Pages 1653-1656

  Vajda, Zsolt ^a   Miloslavski, E ^a   Guthe T ^a   Fischer, S ^a   Albes, G ^a   Heuschmid, A ^a   Henkes, H ^a,b  

^a KATHARINENHOSPITAL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MALE; TREATMENT OUTCOME; VERTEBRAL ARTERY STENOSIS;

AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME; TUBULIN MODULATORS; VERTEBROBASILAR INSUFFICIENCY;

EID: 70349932083     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1715     Document Type: Article

References (25)

1. Wityk RJ, Chang HM, Rosengart A, et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998;55:470-478 (Pubitemid 28182692)
2. Caplan LR, Amarenco P, Rosengart A, et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992;42:1505-1512
3. Spetzler RF, Hadley MN, Martin NA, et al. Vertebrobasilar insufficiency. Part 1. Microsurgical treatment of extracranial vertebrobasilar disease. J Neurosurg 1987;66:648-661 (Pubitemid 17072981)
4. Blacker DJ, Flemming KD, Wijdicks EF. Risk of ischemic stroke in patients with symptomatic vertebrobasilar stenosis undergoing surgical procedures. Stroke 2003;34:2659-2663
5. Chastain HD 2nd, Campbell MS, Iyer S, et al. Extracranial vertebral artery stent placement: in-hospital and follow-up results. J Neurosurg 1999;91:547-552
6. Motarjeme A, Keifer JW, Zuska AJ. Percutaneous transluminal angioplasty of the vertebral arteries. Radiology 1981;139:715-717 (Pubitemid 11072800)
7. Albuquerque FC, Fiorella D, Han P, et al. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery 53:607-14, 2003, discussion 614-616 (Pubitemid 37055940)
8. Tsutsumi M, Kazekawa K, Onizuka M, et al. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology 2007;49:253-257 (Pubitemid 46332320)
9. Kim SR, Baik MW, Yoo SH, et al. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique: report of two cases. J Neurosurg 2007;106:907-911
10. Weber W, Mayer TE, Henkes H, et al. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol 2005;56:240-247 (Pubitemid 41486995)
11. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392
12. Akins PT, Kerber CW, Pakbaz RS. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? - a single-center consecutive case series. J Invasive Cardiol 2008;20:14-20
13. Lin YH, Hung CS, Tseng WY, et al. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc 2008;107:253-258
14. Lugmayr H, Kastner M, Fröhler W, et al. Sirolimus-eluting stents for the treatment of symptomatic extracranial vertebral artery stenoses: early experience and 6-month follow-up [in German]. Rofo 2004;176:1431-1435 (Pubitemid 39382288)
15. Gupta R, Al-Ali F, Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562-2566 (Pubitemid 44454680)
16. Edgell RC, Yavagal DR, Drazin D, et al. Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents. J Neuroimaging 2008 Nov 7. [Epub ahead of print]
17. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-453
18. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231 (Pubitemid 38067635)
19. Slottow TL, Waksman R. Drug-eluting stent safety. Am J Cardiol 2007;100:10M-17M.
20. Dietz U, Holz N, Dauer C, et al. Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting. Heart 2006;92:80-84. Epub 2005 May 9 (Pubitemid 43021862)
21. Qureshi AI, Kirmani JF, Harris-Lane P, et al. Vertebral artery origin stent placement with distal protection: technical and clinical results. AJNR Am J Neuroradiol 2006;27:1140-1145 (Pubitemid 44897703)
22. Lin YH, Juang JM, Jeng JS, et al. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis. J Endovasc Ther 2004;11:719-726
23. Cloud GC, Crawley F, Clifton A, et al. Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series. J Neurol Neurosurg Psychiatry 2003;74:586-590 (Pubitemid 36528901)
24. Lin YH, Liu YC, Tseng WY, et al. The impact of lesion length on angiographic restenosis after vertebral artery origin stenting. Eur J Vasc Endovasc Surg 2006;32:379-385
25. Taylor RA, Siddiq F, Suri MF, et al. Risk factors for in-stent restenosis after vertebral ostium stenting. J Endovasc Ther 2008;15:203-212 (Pubitemid 351628573)